Management ChangeJul 16, 2026, 09:01 AM
Arcutis Appoints Christopher Peetz to Board of Directors
AI Summary
Arcutis Biotherapeutics, Inc. announced the appointment of Christopher Peetz to its Board of Directors, effective July 15, 2026. Mr. Peetz, currently the co-founder and CEO of Mirum Pharmaceuticals, brings extensive experience in leading biopharmaceutical companies through periods of expansion, product development, and commercialization. His strategic insight and operational expertise are expected to be invaluable as Arcutis focuses on growing its ZORYVE franchise and expanding its pipeline.
Key Highlights
- Christopher Peetz appointed to Arcutis Board of Directors, effective July 15, 2026.
- Mr. Peetz is currently the co-founder and Chief Executive Officer of Mirum Pharmaceuticals.
- He has a track record of leading biopharmaceutical companies through expansion, product development, and commercialization.
- His expertise is expected to strengthen the Board in growing the ZORYVE franchise and expanding the pipeline.
- He previously held leadership roles at Flashlight Therapeutics, Tobira, Jennerex Biotherapeutics, and Onyx Pharmaceuticals.
Price Impact
More from ARQT